DSP Healthcare Fund holds 34 instruments (92.16% equity), led by IPCA Laboratories Limited (8.13%), Sun Pharmaceutical Industries Limited (7.44%) and Cipla Limited (7.18%), as of its 30 September 2026 SEBI-mandated monthly disclosure.
This page shows the complete disclosed portfolio of DSP Healthcare Fund, managed by DSP Mutual Fund, based on its monthly portfolio disclosure dated 30 September 2026. The fund holds 34 instruments with an equity allocation of 92.16%. Percentages are of net assets (% to NAV). Click any stock to see every other mutual fund that also holds it.
DSP Healthcare Fund's top 10 holdings account for 59.35% of its portfolio, more concentrated than the Thematic category average of 49.2%. Healthcare is its largest sector exposure at 91.14% of net assets, spread across 2 sectors in total. Since its 31 August 2026 disclosure, the fund added 1 new position and exited 0 positions, with MANIPAL HEALTH ENTERPRISES L seeing the largest move (-1.85pp to 1.85%).
Equity holdings grouped by sector, % to NAV. "Other" covers debt, cash and other non-equity instruments, plus any equity holding without a classified sector.
Equity holdings compared between the fund's two latest monthly disclosures. Weights are % to NAV; weight moves can also reflect price changes, not only buying or selling.
| Stock | Weight | Change |
|---|---|---|
| Alkem Laboratories Limited | 4.08% → 4.75% | ▲ +0.67 |
| Indoco Remedies Limited | 2.06% → 2.26% | ▲ +0.2 |
| INTUITIVE SURGICAL INC | 1.76% → 1.95% | ▲ +0.19 |
| Gland Pharma Limited | 5.98% → 6.15% | ▲ +0.17 |
| GRAIL INC | 0.17% → 0.31% | ▲ +0.14 |
| Stock | Weight | Change |
|---|---|---|
| MANIPAL HEALTH ENTERPRISES L | 3.7% → 1.85% | ▼ -1.85 |
| Sai Life Sciences Limited | 7.45% → 6.52% | ▼ -0.93 |
| IPCA Laboratories Limited | 8.74% → 8.13% | ▼ -0.61 |
| Sun Pharmaceutical Industries Limited | 7.95% → 7.44% | ▼ -0.51 |
| Pfizer Limited | 3.22% → 2.72% | ▼ -0.5 |
| Apollo Hospitals Enterprise Limited | 6.47% → 6.07% | ▼ -0.4 |
| GLOBUS MEDICAL INC - A | 5.44% → 5.15% | ▼ -0.29 |
| Thyrocare Technologies Limited | 2.11% → 1.91% | ▼ -0.2 |
| Cipla Limited | 7.35% → 7.18% | ▼ -0.17 |
% to NAV of the fund's current top holdings over its last 6 monthly disclosures (Apr – Sept 2026).
New to reading these? See How to Read a Mutual Fund's Monthly Portfolio Disclosure, or check terms like % to NAV in the glossary.
Source: DSP Mutual Fund's SEBI-mandated monthly portfolio disclosure, dated 30 September 2026. Data is for information only, not investment advice. Holdings may have changed since the disclosure date.